Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ocular Therapeutix, Inc.(OCUL) | 1,219,724 | 1,014,940 | -204,784 | $8.94M | $9.42M | 13.15% | +$478.1K |
| Cidara Therapeutics Inc | 125,708 | 179,569 | +53,861 | $2.71M | $8.75M | 12.21% | +$6.04M |
| Whitehawk Therapeutics, Inc.(WHWK) | 3,410,402 | 3,410,402 | 0 | $6.07M | $6.38M | 8.90% | +$306.9K |
| Soleno Therapeutics Inc | 67,136 | 63,436 | -3,700 | $4.80M | $5.31M | 7.42% | +$517.8K |
| Tourmaline Bio Inc | 426,882 | 283,682 | -143,200 | $6.49M | $4.54M | 6.33% | -$1.96M |
| Ascendis Pharma A/SADR(ASND) | 23,340 | 22,576 | -764 | $3.64M | $3.90M | 5.44% | +$258.8K |
| Insmed Incorporated(INSM) | 106,074 | 37,070 | -69,004 | $8.09M | $3.73M | 5.21% | -$4.36M |
| argenx SEADR(ARGX) | 7,023 | 6,702 | -321 | $4.16M | $3.69M | 5.16% | -$462.4K |
| Praxis Precision Medicines, Inc.(PRAX) | 87,141 | 74,087 | -13,054 | $3.30M | $3.12M | 4.35% | -$184.7K |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 9,575 | 26,283 | +16,708 | $1.19M | $2.79M | 3.89% | +$1.60M |
| Trevi Therapeutics, Inc.(TRVI) | 785,961 | 493,735 | -292,226 | $4.94M | $2.70M | 3.77% | -$2.24M |
| Oculis Holding AG(OCS) | 125,000 | 106,718 | -18,282 | $2.38M | $2.07M | 2.89% | -$307.4K |
| Revolution Medicines, Inc.(RVMD) | 66,662 | 55,693 | -10,969 | $2.36M | $2.05M | 2.86% | -$308.2K |
| Helix Acquisition Corp IiCL A | 187,257 | 187,257 | 0 | $2.12M | $1.99M | 2.78% | -$127.3K |
| Terns Pharmaceuticals Inc | 325,550 | 463,864 | +138,314 | $898.5K | $1.73M | 2.42% | +$831.7K |
| Surrozen, Inc.(SRZN) | 170,000 | 170,000 | 0 | $1.98M | $1.52M | 2.12% | -$462.4K |
| Bright Minds Biosciences Inc.(DRUG) | 59,748 | 48,474 | -11,274 | $2.16M | $1.27M | 1.77% | -$889.5K |
| Taysha Gene Therapies, Inc.(TSHA) | 0 | 485,669 | +485,669 | $0 | $1.12M | 1.57% | +$1.12M |
| Akero Therapeutics Inc | 0 | 19,772 | +19,772 | $0 | $1.06M | 1.47% | +$1.06M |
| Zymeworks Inc.(ZYME) | 68,459 | 83,655 | +15,196 | $815.3K | $1.05M | 1.47% | +$234.5K |
| Liquidia Corporation(LQDA) | 153,482 | 75,876 | -77,606 | $2.26M | $945.4K | 1.32% | -$1.32M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 21,290 | 23,814 | +2,524 | $770.9K | $865.9K | 1.21% | +$95.0K |
| Verastem, Inc.(VSTM) | 176,000 | 150,414 | -25,586 | $1.06M | $624.2K | 0.87% | -$437.1K |
| Fulcrum Therapeutics, Inc.(FULC) | 0 | 59,650 | +59,650 | $0 | $410.4K | 0.57% | +$410.4K |
| Unicycive Therapeutics, Inc.(UNCY) | 0 | 62,899 | +62,899 | $0 | $300.0K | 0.42% | +$300.0K |
| Rapport Therapeutics, Inc.(RAPP) | 16,400 | 20,000 | +3,600 | $164.5K | $227.4K | 0.32% | +$62.9K |
| Artiva Biotherapeutics, Inc.(ARTV) | 45,456 | 45,456 | 0 | $136.4K | $68.6K | 0.10% | -$67.7K |
| Nuvation Bio Inc.W EXP 07 07 2027(NUVB) | 90,832 | 90,832 | 0 | $17.5K | $24.5K | 0.03% | +$7.0K |
| Edgewise Therapeutics, Inc.(EWTX) | 85,454 | 0 | -85,454 | $1.88M | $0 | — | -$1.88M |
| Enliven Therapeutics Inc | 115,805 | 0 | -115,805 | $0 | $0 | — | $0 |
| Enliven Therapeutics Inc | 265,269 | 0 | -265,269 | $5.22M | $0 | — | -$5.22M |
| Forte Biosciences Inc | 18,469 | 0 | -18,469 | $143.3K | $0 | — | -$143.3K |
| Gilead Sciences, Inc.(GILD) | 9,298 | 0 | -9,298 | $1.04M | $0 | — | -$1.04M |
| Merck & Co., Inc.(MRK) | 22,994 | 0 | -22,994 | $2.06M | $0 | — | -$2.06M |
| Mereo BioPharma Group plcADS(MREO) | 791,815 | 0 | -791,815 | $1.78M | $0 | — | -$1.78M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 83,350 | 0 | -83,350 | $555.9K | $0 | — | -$555.9K |
| Unicycive Therapeutics Inc | 2,352,887 | 0 | -2,352,887 | $1.35M | $0 | — | -$1.35M |
| Verve Therapeutics Inc | 162,724 | 0 | -162,724 | $743.6K | $0 | — | -$743.6K |